Tumor necrosis factor-α gene polymorphism and inflammatory process in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005
Correlation of IL-1 alpha and IL-4 promotor region gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006
Clinical course of cystic fibrosis lung disease and tumour necrosis factor-β gene polymorphism Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008
Tumour necrosis factor-α and lymphotoxin-α gene polymorphisms in cystic fibrosis lung disease Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
The relationship of IL-4 cytokine gene polymorphisms, HRCT and histopathological score in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
Cytokines gene polymorphisms (TNFA, LTA, IL1B, IL1RN and IL10) in children with chronic bronchopulmonary disease and cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004
Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005
Genetic polymorphisms in TNF genes and tuberculosis in cystic fibrosis patients Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Source: Eur Respir J 2008; 32: 372-378 Year: 2008
Effect of MUC5B gene polymorphism on survival in a Lebanese population of patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018
Association of transforming growth factor-ß1 and angiotensinogen G-6A gene polymorphisms influences idiopathic pulmonary fibrosis disease progression Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
TNF-alpha and TNF-beta gene polymorphism in pulmonary sarcoidosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 520s Year: 2006
Association of the TNF gene promoter polymorphism with serum tumor necrosis factor-alpha levels in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 522s Year: 2006
The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012
Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005
The association of IL4 and IL4RA genes polymorphisms with pulmonary function and atopy markers in bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 136s Year: 2004
IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007
MUC5B genotype affects survival of patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019
Level of tumor necrosis factor-α in induced sputum and TNF-α gene promoter polymorphism in Korean COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 132s Year: 2007
The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012